NCT00243347View on ClinicalTrials.gov

The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

July 31, 2009

Conditions
CarcinomaNon-Small-Cell Lung CarcinomaHead and Neck Neoplasms
Interventions
DRUG

AZD2171

oral tablet

Trial Locations (2)

Unknown

Research Site, Houston

Research Site, Barcelona

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00243347 - The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer | Biotech Hunter | Biotech Hunter